Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-01-29 @ 7:56 PM
Study NCT ID:
NCT00678392
Status:
COMPLETED
Last Update Posted:
2019-01-09
First Post:
2008-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09-03
Start Date Type:
ACTUAL
Primary Completion Date:
2010-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02-25
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-12
First Submit QC Date:
None
Study First Post Date:
2008-05-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-02-25
Results First Submit QC Date:
None
Results First Post Date:
2012-03-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-10-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-12-20
Last Update Post Date:
2019-01-09
Last Update Post Date Type:
ACTUAL